Home > Resources > Company Profiles > Thermo Fisher Scientific, Incorporated

Thermo Fisher Scientific, Incorporated (TMO)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

Marijn E. Dekkers , CEO/President/Director

www.thermofisher.com

Industry: Technology

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics to make the world healthier, cleaner and safer.

News Feeds

Final Glance: Health Care Equipment companies AP
Nov 21 2008
Midday Glance: Health Care Equipment companies AP
Nov 21 2008
Early Glance: Health Care Equipment companies AP
Nov 21 2008
Fitch affirms debt ratings for Thermo Fisher AP
Nov 11 2008
Thermo Fisher shares slip after revenue shortfall AP
Oct 23 2008
Movers roundup: Chipotle, Thermo Fisher Scientific AP
Oct 23 2008
Outlook roundup: Union Pacific, Thermo Fisher AP
Oct 23 2008
Thermo Fisher Scientific narrows 2008 outlook AP
Oct 23 2008
Thermo Fisher Scientific reports 3Q profit rise AP
Oct 23 2008

Press Releases

Thermo Fisher Scientific Strengthens Anatomical Pathology Portfolio with Acquisition of Raymond A. Lamb Nov-11-2008, 09:00AM EST
Thermo Fisher Scientific Provides Notice of Conversion Right to Debenture Holders Nov-03-2008, 05:00PM EST
Opportunities for Life Science Suppliers Plentiful in Rapidly Growing miRNA Research Markets Oct-27-2008, 08:54AM EDT
Thermo Fisher Scientific Reports Record 2008 Third Quarter Results from Continuing Operations Oct-23-2008, 06:00AM EDT
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 23, 2008 Oct-07-2008, 09:00AM EDT

News From Around the Web

News

Final Glance: Health Care Equipment companies (Boston Globe)

Nov 21 2008
Midday Glance: Health Care Equipment companies (Boston Globe)

Nov 21 2008
Thermo Fisher Scientific Accelerates Biomarker Research at Pronota (PharmaLive)

Nov 20 2008
Health Care Equipment companies shares down at the close of trading (Canadian Business Online)

Nov 19 2008
Early Glance: Health Care Equipment companies (Businessweek)

Nov 19 2008
Pharmanet Development Group Enhances Immunochemistry Capabilties (PharmaLive)

Nov 18 2008

Employees

Number of Employees: 33,000

Revenue per Employee: $288,334

Top Executives

Seth H. Hoogasian, Senior VP/Secretary/General Counsel

Fredric T. Walder, Senior VP, Divisional

Marc N. Casper, Executive VP/COO

Peter E. Hornstra, Vice President/Chief Accounting Officer

Alan J. Malus, Senior VP

Guy Broadbent, Senior VP

Joseph R. Massaro, Senior VP, Divisional

Alexander G. Stachtiaris, Senior VP, Divisional

Peter M. Wilver, Senior VP/CFO

Stephen G. Sheehan, Senior VP, Divisional

Board of Directors

Seth H. Hoogasian, Senior VP/Secretary/General Counsel

Michael A. Bell, Director

Elaine S. Ullian, Director

Scott M. Sperling, Director

Judy C. Lewent, Director

William G. Parrett, Director

Peter J. Manning, Director

Jim P. Manzi, Chairman of the Board/Director

Stephen P. Kaufman, Director

Dr.Michael E. Porter, Director

Financials

Quarterly

Annual

Income Statement	10/2008	07/2008	04/2008	02/2008
Sales	1.68 Bil.	1.74 Bil.	1.66 Bil.	NA
Gross Operating Profit	912.2 Mil.	967.2 Mil.	898.9 Mil.	2.62 Bil.
Operating Income before D & A (EBITDA)	301.7 Mil.	324.8 Mil.	295.3 Mil.	2.62 Bil.
Total Income Before Interest Expenses (EBIT)	298.3 Mil.	344.1 Mil.	308 Mil.	2.62 Bil.
Total Net Income	221.5 Mil.	249.5 Mil.	233 Mil.	239.8 Mil.
Basic EPS, Total	0.53	0.59	0.56	0.57
Diluted EPS, Total	0.51	0.56	0.54	0.54

BALANCE STATEMENT	10/2008	07/2008	04/2008	02/2008
Cash and Equivalents	1.24 Bil.	1.01 Bil.	734 Mil.	636.2 Mil.
Total Assets	4.44 Bil.	4.3 Bil.	3.99 Bil.	3.68 Bil.
Total Liabilities	1.84 Bil.	1.88 Bil.	1.91 Bil.	1.91 Bil.
Total Capitalization	17.18 Bil.	17.11 Bil.	17.54 Bil.	16.53 Bil.

Cash Flow	10/2008	07/2008	04/2008	02/2008
Net Cash From Continuing Operations	NA	NA	NA	NA
Net Cash From Investing Activities	NA	NA	NA	NA
Net Cash From Financing Activities	NA	NA	NA	NA
Net Change in Cash & Cash Equivalents	NA	NA	NA	NA

Income Statement	2008	2007	2006	2005
Sales	6.39 Bil.	1.98 Bil.	1.31 Bil.	1.13 Bil.
Gross Operating Profit	3.36 Bil.	1.81 Bil.	1.32 Bil.	1.08 Bil.
Operating Income before D & A (EBITDA)	1.02 Bil.	528.44 Mil.	403.66 Mil.	319.48 Mil.
Total Income Before Interest Expenses (EBIT)	1.11 Bil.	261.3 Mil.	312.61 Mil.	259.22 Mil.
Total Net Income	761.1 Mil.	168.94 Mil.	223.22 Mil.	361.84 Mil.
Basic EPS, Total	1.81	0.86	1.38	2.22
Diluted EPS, Total	1.72	0.84	1.36	2.17

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	636.2 Mil.	667.43 Mil.	214.33 Mil.	326.89 Mil.
Total Assets	3.68 Bil.	3.66 Bil.	1.35 Bil.	1.47 Bil.
Total Liabilities	1.91 Bil.	2.15 Bil.	791.66 Mil.	578.73 Mil.
Total Capitalization	16.53 Bil.	16.09 Bil.	3.26 Bil.	2.89 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	410.11 Mil.	272.79 Mil.	250.01 Mil.
Net Cash From Investing Activities	NA	283.45 Mil.	-753.48 Mil.	34.15 Mil.
Net Cash From Financing Activities	NA	-260.1 Mil.	390.86 Mil.	-183.22 Mil.
Net Change in Cash & Cash Equivalents	NA	453.11 Mil.	-112.56 Mil.	131.11 Mil.

Thermo Fisher Scientific, Incorporated (TMO)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request